(-0.22%) 5 011.12 points
(0.06%) 37 775 points
(-0.52%) 15 601 points
(-0.22%) $82.51
(1.99%) $1.746
(0.25%) $2 394.40
(-0.28%) $28.32
(-0.54%) $949.00
(0.29%) $0.940
(0.54%) $11.05
(0.17%) $0.804
(0.10%) $94.15
Live Chart Being Loaded With Signals
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs...
Stats | |
---|---|
Today's Volume | 11 062.00 |
Average Volume | 13 221.00 |
Market Cap | 6.84M |
EPS | $0 ( 2024-04-02 ) |
Next earnings date | ( $0 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.110 |
ATR14 | $0.108 (2.25%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-28 | Zauderer Maurice | Buy | 38 610 | Common Stock |
2024-03-28 | Zauderer Maurice | Buy | 38 610 | Warrant (Right to Buy) |
2024-03-28 | Friedberg Albert | Buy | 102 960 | Common Stock |
2024-03-28 | Friedberg Albert | Buy | 102 960 | Warrant (Right to Buy) |
2024-03-20 | Evans Elizabeth E. | Buy | 1 341 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
99.87 |
Last 100 transactions |
Buy: 40 295 196 | Sell: 9 809 782 |
Vaccinex Inc Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Vaccinex Inc Financials
Annual | 2023 |
Revenue: | $570 000 |
Gross Profit: | $451 000 (79.12 %) |
EPS: | $-43.68 |
Q4 | 2023 |
Revenue: | $0 |
Gross Profit: | $-26 500.00 (0.00 %) |
EPS: | $-3.72 |
Q3 | 2023 |
Revenue: | $20 000.00 |
Gross Profit: | $-11 000.00 (-55.00 %) |
EPS: | $-15.26 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $-30 000.00 (0.00 %) |
EPS: | $-24.54 |
Financial Reports:
No articles found.
Vaccinex Inc
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab, a humanized monoclonal antibody that completed and planned Phase 1b/2 clinical trials for the treatment of non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), Huntington's disease, Alzheimer's disease, osteosarcoma, and melanoma. The company is also developing VX5, a human antibody to CXCL13 that is in preclinical development for the treatment of MS and for other autoimmune disorders. Vaccinex, Inc. was incorporated in 2001 and is headquartered in Rochester, New York.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators